Ocular Science, Inc.

Based in the US, Ocular Science, Inc. , operates as a biotech company that provides affordable products to physicians and their patients in the corrective eye care industry. Based in Manhattan Beach, the US and founded in 2015, Ocular Science, Inc. focuses on the corrective eye care industry.

The company provides affordable products to healthcare professionals and their patients. Ocular Science has developed a range of medical devices and treatments for various ocular conditions. Ocular Science is at the forefront of the corrective eye care industry, delivering innovative and cost-effective therapeutic solutions that enhance patient compliance. The company’s primary offerings include advanced medical devices and treatments designed for the diagnosis and management of various ocular conditions.

By engaging with a robust medical advisory board of renowned ophthalmology experts, Ocular Science focuses on producing products that are user-friendly and adhere to the evolving needs of healthcare providers and their patients. The company’s products are utilized by ophthalmologists and optometrists across North America, Europe, and select markets in Asia, addressing persistent challenges in eye care. Ocular Science operates within a structured revenue generation model that primarily involves direct transactions with healthcare professionals and institutions. The company engages in B2B partnerships whereby ophthalmologists and eye care facilities purchase its flagship products directly, creating a streamlined supply chain that ensures efficient delivery and service.

Revenue is generated through volume sales of its proprietary medical devices and corrective solutions, with structured pricing plans tailored for both small practices and larger hospital systems. These transactions foster ongoing relationships with clinical partners, allowing for potential subscription-based access to new product lines and updates. The company plans to expand its product offerings and enhance its market presence through strategic partnerships and collaborations. Current initiatives include the development of new medical devices aimed at improving patient outcomes in eye care.